These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7357741)

  • 21. Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans.
    Wilz DR; Gray RW; Dominguez JH; Lemann J
    Am J Clin Nutr; 1979 Oct; 32(10):2052-60. PubMed ID: 484524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of plasma vitamin D metabolites for radioimmunoassay.
    Taylor GA; Peacock M; Pelc B; Brown W; Holmes A
    Clin Chim Acta; 1980 Dec; 108(2):239-46. PubMed ID: 6969637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of pituitary hormones in regulating renal vitamin D metabolism in man.
    Brown DJ; Spanos E; MacIntyre I
    Br Med J; 1980 Feb; 280(6210):277-8. PubMed ID: 7357340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A binding assay for 25-hydroxycalciferols and 24R,25-dihydroxycalciferols using bovine plasma globulin.
    Hollis BW; Burton JH; Draper HH
    Steroids; 1977 Aug; 30(2):285-93. PubMed ID: 929649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives.
    Juttmann JR; Buurman CJ; De Kam E; Visser TJ; Birkenhäger JC
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):225-36. PubMed ID: 6973423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent measurement of plasma levels of vitamin D3 and five of its metabolites in normal humans, chronic renal failure patients, and anephric subjects.
    Lambert PW; DeOreo PB; Hollis BW; Fu IY; Ginsberg DJ; Roos BA
    J Lab Clin Med; 1981 Oct; 98(4):536-48. PubMed ID: 6270222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer.
    Fraser WD; Durham BH; Berry JL; Mawer EB
    Ann Clin Biochem; 1997 Nov; 34 ( Pt 6)():632-7. PubMed ID: 9367000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assay of 1,25-dihydroxy vitamin D3 by isotope dilution--mass fragmentography.
    Björkhem I; Holmberg I; Kristiansen T; Pedersen JI
    Clin Chem; 1979 Apr; 25(4):584-8. PubMed ID: 466767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple and sensitive assay for 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human serum.
    Imawari M; Kozawa K; Yoshida T; Osuga T
    Clin Chim Acta; 1982 Sep; 124(1):63-73. PubMed ID: 6982126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of vitamin D and its metabolites in plasma from normal and anephric man.
    Shepard RM; Horst RL; Hamstra AJ; DeLuca HF
    Biochem J; 1979 Jul; 182(1):55-69. PubMed ID: 227368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism.
    Bone HG; Zerwekh JE; Haussler MR; Pak CY
    J Clin Endocrinol Metab; 1979 May; 48(5):877-9. PubMed ID: 429532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of active metabolites of vitamin D on manifestations of primary hyperparathyroidism].
    Riancho JA; Pesquera C; Amado JA; Otero M; Freijanes J; Napal J; González Macías J
    Med Clin (Barc); 1989 Oct; 93(10):361-4. PubMed ID: 2607788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Competitive protein-binding assay for 24,25-dihydroxycholecalciferol.
    Taylor CM; De Silva P; Hughes SE
    Calcif Tissue Res; 1977 May; 22 Suppl():40-4. PubMed ID: 912556
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma profile of hydroxylated vitamin D metabolites: methods and results in normals for spring-winter in Southern Finland.
    Dabek JT
    Ann Clin Res; 1980 Feb; 12(1):17-24. PubMed ID: 7377752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substrate-product relation of 1-hydroxylase activity in primary hyperparathyroidism.
    LoCascio V; Adami S; Galvanini G; Ferrari M; Cominacini L; Tartarotti D
    N Engl J Med; 1985 Oct; 313(18):1123-5. PubMed ID: 3840228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Measurement of plasma 1,25 dihydrovitamin D. Normal and pathological values in adults (author's transl)].
    Ulmann A; Lair M; Bader C; Funck-Brentano JL
    Nouv Presse Med; 1981 Apr; 10(17):1393-5. PubMed ID: 7015271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy.
    Weisman Y; Fattal A; Eisenberg Z; Harel S; Spirer Z; Harell A
    Br Med J; 1979 Sep; 2(6189):521-3. PubMed ID: 497670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.